Stay updated on Ziftomenib in AML Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib in AML Clinical Trial page.

Latest updates to the Ziftomenib in AML Clinical Trial page
- Check3 days agoChange DetectedPage revision updated to v3.0.2, replacing v3.0.1; the 'Back to Top' link was removed. No substantive changes to core content detected.SummaryDifference0.5%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.5%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of location data.SummaryDifference65%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%
- Check38 days agoChange DetectedThe web page has updated its version from v2.16.10 to v2.16.11 and changed the date from 2025-06-27 to 2025-08-06.SummaryDifference0.7%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Ziftomenib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib in AML Clinical Trial page.